Wiśniowska, B.; Giebułtowicz, J.; Piotrowski, R.; Kułakowski, P.; Polak, S.
Development and Performance Verification of the PBPK Model for Antazoline and Its Metabolite and Its Utilization for Pharmacological Hypotheses Formulating. Pharmaceuticals 2022, 15, 379.
https://doi.org/10.3390/ph15030379
AMA Style
Wiśniowska B, Giebułtowicz J, Piotrowski R, Kułakowski P, Polak S.
Development and Performance Verification of the PBPK Model for Antazoline and Its Metabolite and Its Utilization for Pharmacological Hypotheses Formulating. Pharmaceuticals. 2022; 15(3):379.
https://doi.org/10.3390/ph15030379
Chicago/Turabian Style
Wiśniowska, Barbara, Joanna Giebułtowicz, Roman Piotrowski, Piotr Kułakowski, and Sebastian Polak.
2022. "Development and Performance Verification of the PBPK Model for Antazoline and Its Metabolite and Its Utilization for Pharmacological Hypotheses Formulating" Pharmaceuticals 15, no. 3: 379.
https://doi.org/10.3390/ph15030379
APA Style
Wiśniowska, B., Giebułtowicz, J., Piotrowski, R., Kułakowski, P., & Polak, S.
(2022). Development and Performance Verification of the PBPK Model for Antazoline and Its Metabolite and Its Utilization for Pharmacological Hypotheses Formulating. Pharmaceuticals, 15(3), 379.
https://doi.org/10.3390/ph15030379